Burjeel Holdings Appoints Reuben George Joseph as Chief Financial Officer to Support Next Phase of Growth
Burjeel Holdings PLC, a leading super-specialty healthcare services provider operating across the Gulf Cooperation Council (GCC) region, has announced the appointment of Reuben George Joseph as Chief Financial Officer (CFO). The appointment was approved by the company’s Board of Directors and will take effect on 1 October 2026.
The leadership change comes as Burjeel Holdings continues to expand its healthcare platform and advance its strategic growth agenda across the GCC. With extensive experience in finance, corporate development, mergers and acquisitions, transformation and governance, Joseph is expected to strengthen the Group’s financial leadership and support its priorities as it moves into its next phase of development.
Burjeel Holdings is listed on the Abu Dhabi Securities Exchange under the symbol BURJEEL and is focused on providing specialised and super-specialty healthcare services across the region. The Group’s growth strategy requires strong financial management, disciplined capital allocation and effective oversight of its expanding operations, making the CFO role an important component of its broader corporate strategy.
Reuben George Joseph Brings Extensive Healthcare and Finance Experience
Joseph currently serves as General Manager – Transformation at Burjeel Holdings, where he has been closely involved in several areas that are central to the Group’s strategic development.
His current responsibilities have provided him with direct exposure to the organisation’s strategic finance activities, capital allocation decisions, corporate development initiatives and transformation agenda. This experience is expected to provide continuity as he moves into the CFO position.
His familiarity with Burjeel Holdings’ operations and strategic priorities could also support a smooth transition into the new role. Rather than joining the organisation from outside, Joseph is moving into the CFO position after already working closely with the Group’s leadership and its transformation and financial priorities.
His appointment therefore combines internal institutional knowledge with more than two decades of professional experience across a broad range of financial and corporate functions.
As a Chartered Accountant with more than 20 years of experience, Joseph has developed expertise across financial reporting, controllership and governance, treasury, corporate development, mergers and acquisitions, restructuring, valuation and finance transformation.
These areas are particularly relevant to a healthcare organisation operating in a competitive and evolving regional market. Financial reporting and governance support transparency and accountability, while treasury and capital allocation are critical to managing financial resources effectively.
Corporate development and M&A experience can also support companies pursuing expansion strategies, partnerships and acquisitions. Meanwhile, restructuring, valuation and finance transformation capabilities can help organisations improve financial processes and align their finance functions with long-term strategic objectives.
Previous Leadership at VPS Health
Before joining Burjeel Holdings, Joseph served as Chief Financial Officer of VPS Health, giving him substantial experience within the healthcare sector.
His previous senior-level responsibilities have provided exposure to the financial and operational complexities associated with healthcare businesses. In addition to his executive experience, Joseph has held board and senior advisory positions, further broadening his understanding of corporate governance, strategic decision-making and organisational leadership.
His combination of healthcare-sector experience and broader financial expertise is expected to support Burjeel Holdings as it continues to develop its business.
The move also reflects the importance of finance leadership in healthcare companies as they balance investment in infrastructure, clinical capabilities, technology and workforce development with the need for sustainable financial performance.
For a growing healthcare group, the CFO function extends beyond traditional financial reporting. It can play a central role in evaluating investment opportunities, managing capital, supporting strategic planning and ensuring that financial resources are directed toward initiatives capable of creating long-term value.
Supporting Burjeel Holdings’ Growth Strategy
Joseph’s appointment takes place against the backdrop of Burjeel Holdings’ continued focus on growth and transformation.
As a super-specialty healthcare services provider, the Group operates in a sector where demand for advanced medical services continues to evolve. Healthcare organisations must respond to changing patient needs while investing in medical infrastructure, specialised services, technology and clinical talent.
Strong financial leadership can help ensure that such investments are supported by appropriate financial planning and capital discipline.
Joseph’s experience in strategic finance and capital allocation is therefore expected to be particularly relevant to the Group’s next stage of development. His existing involvement in Burjeel’s transformation agenda also provides an understanding of the organisation’s priorities and ongoing initiatives.
The appointment is intended to strengthen the Group’s ability to execute its strategy while maintaining appropriate financial oversight.
Continuity in Financial Leadership
Burjeel Holdings also confirmed that Muhammed Shihabuddin will remain in his position as Chief Financial Officer until 30 September 2026, as previously announced.
Shihabuddin’s continuation through the end of September is intended to support an orderly transition before Joseph formally assumes the CFO position on 1 October.
A structured transition between senior financial leaders can be important for maintaining continuity in financial reporting, governance, strategic planning and other critical finance functions. It can also provide the incoming CFO with an opportunity to assume responsibilities while preserving institutional knowledge and ensuring that ongoing priorities remain on track.
The transition is particularly relevant for a publicly listed healthcare group, where the finance function has responsibilities extending across financial reporting, regulatory requirements, investor communications, governance and strategic decision-making.
By planning the leadership transition in advance, Burjeel Holdings is seeking to minimise disruption and maintain continuity within its financial operations.
Importance of Finance Leadership in Healthcare
The appointment also highlights the increasingly strategic role of finance functions within the healthcare industry.
Healthcare providers must make significant investments to maintain and expand their facilities, acquire advanced medical equipment, recruit specialised professionals and develop new services. At the same time, they must manage operating costs and maintain financial sustainability.
For large healthcare groups, mergers and acquisitions can also form part of an expansion strategy. Evaluating potential transactions requires detailed financial analysis, valuation expertise and careful assessment of strategic fit.
A CFO with experience across M&A, restructuring, valuation and corporate development can contribute to these processes by helping management and boards assess opportunities and risks.
Finance transformation is another area becoming increasingly important. Digital technologies and data-driven systems can change how organisations manage financial information, reporting and decision-making. A modern finance function can provide leadership teams with more timely and useful information to support operational and strategic decisions.
Joseph’s experience across these areas aligns with the broader requirements of a growing healthcare organisation.
Strengthening Governance and Capital Allocation
Governance is another key element of the CFO role at a publicly listed company.
Effective governance requires robust financial controls, accurate reporting, transparent processes and appropriate oversight. The CFO works closely with senior management, the Board of Directors and other stakeholders to ensure that financial activities support the organisation’s broader objectives.
Joseph’s background in controllership and governance is expected to complement his strategic finance experience in this respect.
Capital allocation will also remain an important consideration as Burjeel Holdings advances its growth strategy. Healthcare groups must determine how best to allocate available capital across existing operations, new investments, expansion opportunities and other strategic priorities.
Disciplined capital allocation can help organisations balance growth ambitions with financial sustainability.
Joseph’s current involvement in strategic finance and capital allocation at Burjeel Holdings means that he already has insight into the Group’s approach to these areas. His transition into the CFO role is expected to provide continuity while strengthening the organisation’s ability to integrate financial strategy with its wider transformation programme.
A Leadership Transition Built Around Continuity
The appointment of Joseph represents an internal leadership transition rather than a complete change in financial direction.
His current position as General Manager – Transformation means he is already familiar with Burjeel Holdings’ business environment, strategic priorities and transformation initiatives. This institutional knowledge could help him take on the CFO role with a strong understanding of the Group’s existing financial and operational framework.
At the same time, his previous experience as CFO of VPS Health gives him direct experience in senior financial leadership within the healthcare sector.
The combination of internal knowledge and previous executive experience provides a foundation for continuity as the Group enters its next phase of growth.
The planned handover period with Shihabuddin remaining in the CFO position until 30 September is expected to further support this continuity.
Joseph will formally begin his tenure as Chief Financial Officer on 1 October 2026.
In the new role, he will be responsible for helping guide the Group’s financial strategy while supporting its broader corporate development and transformation priorities. His experience in strategic finance, capital allocation, M&A, restructuring, valuation, governance and finance transformation will be relevant as Burjeel Holdings continues to develop its healthcare platform.
The appointment comes at an important point for the organisation as it seeks to build on its position in the GCC healthcare market and pursue further opportunities for growth.
For Burjeel Holdings, maintaining strong financial leadership will be essential to supporting expansion while ensuring appropriate financial discipline and governance. The Group’s ability to invest in healthcare services, infrastructure, technology and other strategic priorities will depend in part on effective capital management and financial planning.
Joseph’s appointment is intended to reinforce these capabilities.
With more than 20 years of professional experience and existing knowledge of Burjeel Holdings’ strategic and transformation activities, Joseph is positioned to provide continuity while taking on broader responsibility for the Group’s financial leadership.
Meanwhile, Shihabuddin’s continued service through 30 September 2026 will provide a defined transition period before the leadership change takes effect.
Overall, the appointment marks another step in Burjeel Holdings’ efforts to strengthen its leadership structure as it prepares for its next stage of growth. By combining healthcare-sector experience, strategic finance expertise and knowledge of the Group’s transformation agenda, the new CFO is expected to play an important role in supporting Burjeel Holdings’ financial priorities and long-term development across the GCC.
Source link: https://burjeelholdings.com/
